跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 40,893 条关于
“schizophrenia spectrum disorders”
全部
40,893
临床试验
34,902
药物
421
机构
103
资讯
5,467
4个月前
Gabather Initiates Phase II TOTEMS Trial for GT-002 in Schizophrenia Spectrum Disorders
去年
Antipsychotics Show Limited Cognitive Benefits in Schizophrenia Spectrum Disorders
去年
Semaglutide Demonstrates Significant Metabolic Benefits in Schizophrenia Patients on Antipsychotic Therapy
去年
Novel Group Therapy Shows Promise in Treating Mental Health Self-Stigma: Italian Clinical Trial Launches
去年
Bio-Thera's BAT4406F Shows Promise in Neuromyelitis Optica Spectrum Disorders
去年
Experts Highlight Critical Link Between Schizophrenia and Substance Use Disorders, Call for Integrated Treatment Approach
去年
MapLight Therapeutics Initiates Phase 2 Trial of Novel M1/M4 Muscarinic Agonist ML-007C-MA for Schizophrenia Treatment
去年
Boehringer Ingelheim Expands Schizophrenia Pipeline with Sosei Heptares and Autifony Collaborations
去年
Anavex Completes Enrollment in Phase 2 Trial of ANAVEX®3-71 for Schizophrenia Treatment
去年
Late-Stage Clinical Trial Results Expected for Novel Therapies Targeting Weight Loss, Schizophrenia, and Autoimmune Disorders
第 1 页，共 547 页
上一页
下一页
